Clinical Trials Search

Use this page to search all trials that are open to enrollment for adult and pediatric patients. For more information on clinical trials at Sanford Health, call or email Bemidji Clinical Research at (218) 333-4869, Bismarck Clinical Research at (701) 323-5760, Fargo at (701) 234-5890; and Sioux Falls Clinical Research at (605) 328-1388. You can also learn more by visiting clinicaltrials.gov, which is a comprehensive national registry of all clinical trials.

Cancer
Assessment of Patient Satisfaction with Participation in NCCTG Clinical Trials
Study ID: NCCTG N0392
Disease: Other
Stage: Unknown
  Learn More
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with Mgmt Promoter Hypermethylation
Study ID: Alliance A071102
Disease: Brain and Nervous System
Stage: Phase II/III
  Learn More
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Study ID: NRG-BN001
Disease: Brain and Nervous System
Stage: Phase II
  Learn More
A Randomized, Phase III Trial Of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Study ID: NRG-CC001
Disease: Cancer Control
Stage: Phase III
  Learn More
A Randomized Phase II Trial of Tamoxifen versus Z-Endoxifen in Postmenopausal Women with Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
Study ID: Alliance A011203
Disease: Breast - Invasive
Stage: Phase II
  Learn More
Change in Mammographic Density with Metformin Use: A Companion Study to NCIC Study MA.32
Study ID: Alliance A211201
Disease: Breast - Invasive
Stage: N/A
  Learn More
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Men and Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
Study ID: ECOG E2112
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physicians Choice for Metastatic Triple Negative Breast Cancer (mTNBC) (KEYNOTE-119)
Study ID: Merck MK-3475-119 Keynote 119
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Study ID: NRG-BR003
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Study ID: NSABP B-51
Disease: Breast - Invasive
Stage: Phase III
  Learn More
A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy
Study ID: NSABP B-55
Disease: Breast - Invasive
Stage: Phase III
  Learn More
Evaluating targets in Locally advanced breast cancer by Sequencing tumor DNA at diagnosis and After progression
Study ID: SH ELSA
Disease: Breast - Invasive
Stage: Pilot/Feasibility
  Learn More
Nutrition Coaching for Breast Cancer Patients Undergoing Treatment to Decrease Insulin Resistance
Study ID: SH Nutrition Coaching for Breast Cancer Terstriep
Disease: Other
Stage: Pilot/Feasibility
  Learn More
A Phase III Placebo-Controlled, Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy with or without Chemotherapy
Study ID: Alliance A221304
Disease: Cancer Control
Stage: Phase III
  Learn More
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias
Study ID: CTSU A221102
Disease: Other
Stage: N/A
  Learn More
Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Study ID: DCP-001
Disease: Cancer Control
Stage: N/A
  Learn More
A Phase 2 Randomized Study of Efatutazone, an Oral PPAR Agonist, In Combination with Paclitaxel Versus Paclitaxel in Patients with Advanced Anaplastic Thyroid Cancer
Study ID: Alliance A091305
Disease: Thyroid
Stage: Phase II
  Learn More
HUD-liver carcinoma
Study ID: BTG TheraSphere
Disease: HEP (Liver Tumors)
Stage: HDE
  Learn More
A Phase II Randomized Trial Evaluating the Addition of High or Standard Intensity Radiation to Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Cancer
Study ID: CTSU R1201
Disease: Pancreas
Stage: Phase II
  Learn More
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Study ID: CTSU S1505
Disease: Pancreas
Stage: Phase II
  Learn More
Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
Study ID: ECOG E7208
Disease: Colorectal
Stage: Phase II
  Learn More
Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas
Study ID: ECOG-ACRIN EA2142
Disease: Gastrointestinal, Other
Stage: Phase II
  Learn More
A Randomized Open-label Phase III Study of Single Agent Pembrolizumab vs Physicians' Choice of Single Agent Paclitaxel or Docetaxel in Subjects with Advanced/Metastatic Squamous Cancer and Adenocarcinomas of the Esophagus that have Progressed after First-Line Standard Therapy (KEYNOTE-181)
Study ID: Merck MK3475-181 Keynote 181
Disease: Esophagus
Stage: Phase III
  Learn More
NSABP Patient Registry and Biospecimen Profiling Repository
Study ID: NSABP MPR-1
Disease: Colorectal
Stage: Unknown
  Learn More
Phase III open-label, multicenter trial of avelumab (MSB0010718C) in previously treated subjects as a third line treatment of recurrent, metastatic gastric adenocarcinoma.
Study ID: Quintiles EMD Serono Gastric JAVELIN EMR 100070-008
Disease: Gastrointestinal, Other
Stage: Phase III
  Learn More
A Phase III Trial of Enzalutamide (NSC#766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Study ID: CTSU A031201
Disease: Prostate
Stage: Phase III
  Learn More
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Study ID: CTSU R0924
Disease: Prostate
Stage: Phase III
  Learn More
EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.
Study ID: CTSU S0931
Disease: REN (Renal)
Stage: Phase III
  Learn More
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Study ID: CTSU S1216
Disease: Prostate
Stage: Phase III
  Learn More
Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine) Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Fallopian Tube and Peritoneal Primary Cancer
Study ID: GOG 0213
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: Phase III
  Learn More
Can Diet and Physical Activity Modulate Ovarian or Primary Peritoneal Cancer Progression-Free Survival?
Study ID: GOG 0225
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: N/A
  Learn More
A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Study ID: GOG 3005 and AbbVie Hybrid M13-694
Disease: Ovary/Fallopian Tube/Primary Peritoneal
Stage: Phase III
  Learn More
Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer
Study ID: CTSU R0920
Disease: Head & Neck
Stage: Phase III
  Learn More
Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Study ID: Merck MK3475 Keynote 048; PN0048 H&N
Disease: Head & Neck
Stage: Unknown
  Learn More
Randomized, open label, single-site trial to evaluate the safety and effectiveness of a Sanford PROFILE ketogenic diet on stage III-IV squamous cell carcinoma of the head and neck
Study ID: SH Profile for SCCHN
Disease: Head & Neck
Stage: Phase I/II
  Learn More
Understanding and Improving Treatment of Head and Neck Cancer
Study ID: SH Understanding and Improving Treatment of Head and Neck Cancer
Disease: Head & Neck
Stage: N/A
  Learn More
Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-Cell Lymphoma (DLBCL)
Study ID: CTSU S1001
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
Randomized Phase II Study of Lenalidomide R-CHOP (R2CHOP) vs R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) in Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma
Study ID: ECOG E1412
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
Study ID: ECOG E1912
Disease: HEME (Hemetologic)
Stage: Phase III
  Learn More
A Compassionate Use Open-Label Study of Anti IL-5 (Mepolizumab) Treatment in Subjects with Hypereosinophilic Syndrome
Study ID: GSK MHE104317
Disease: HEME (Hemetologic)
Stage: Unknown
  Learn More
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Study ID: Alliance A081105
Disease: Lung
Stage: N/A
  Learn More
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin or Carboplatin and Etoposide
Study ID: CTSU C30610
Disease: Small Cell Lung Cancer
Stage: Phase III
  Learn More
Phase II/III Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer
Study ID: CTSU S1400
Disease: Lung
Stage: Phase II/III
  Learn More
A Randomized Phase II/III Trial of Afatinib Plus Cetuximab Versus Afatinib Alone in Treatment-Naive Patients with Advanced, EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC)
Study ID: CTSU S1403
Disease: Lung
Stage: Phase II/III
  Learn More
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Study ID: ECOG-ACRIN E4512
Disease: Lung
Stage: Phase III
  Learn More
A Randomized, Double-Blind, Phase III Study of Platinum + Pemetrexed Chemotherapy with or without Pembrolizumab (MK-3475) in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects (KEYNOTE-189)
Study ID: Merck MK3475-189; NSCLC
Disease: Non-Small Cell Lung Cancer
Stage: Phase III
  Learn More
RANDOMIZED PHASE II/III TRIAL OF PROPHYLACTIC CRANIAL IRRADIATION WITH OR WITHOUT HIPPOCAMPAL AVOIDANCE FOR SMALL CELL LUNG CANCER
Study ID: NRG CC003
Disease: Cancer Control
Stage: Phase II/III
  Learn More
Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC
Study ID: NRG LU001
Disease: Non-Small Cell Lung Cancer
Stage: Phase II
  Learn More
A Phase III Randomized Trial Comparing Physician/Patient Choice of High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma
Study ID: CTSU S1404
Disease: Melanoma
Stage: Phase III
  Learn More
A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma
Study ID: ECOG-ACRIN EA6134
Disease: Melanoma
Stage: Phase III
  Learn More
Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma
Study ID: ECOG-ACRIN EA6141
Disease: Melanoma
Stage: Phase II/III
  Learn More
Randomized Phase II Study of Maintenance Pemetrexed versus Observation for Patients with Malignant Pleural Mesothelioma Without Progression after First-Line Chmeotherapy
Study ID: CTSU C30901
Disease: Mesothelioma
Stage: Phase II
  Learn More
A Randomized Phase I/II Study of Optimal Induction Therapy of Bortezomib, Dexamethasone and Lenalidomide with or without Elotuzumab (NSC-764479) for Newly Diagnosed High Risk Multiple Myeloma (HRMM)
Study ID: CTSU S1211
Disease: Multiple Myeloma
Stage: Phase I/II
  Learn More
Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Study ID: ECOG E1A11
Disease: Multiple Myeloma
Stage: Phase III
  Learn More
CheckMate 358: Non-Comparative, Two-Cohort, Single-Arm, Open-Label, Phase 1/2 Study of Nivolumab (BMS-936558) in Subjects with Virus-Positive and Virus-Negative Solid Tumors
Study ID: BMS CA209358 HPV H&N; CHECKMATE
Disease: Head & Neck, Gynecologic, Other
Stage: Phase I/II
  Learn More
MY PATHWAY: AN OPEN-LABEL PHASE IIA STUDY EVALUATING TRASTUZUMAB/PERTUZUMAB, ERLOTINIB, VEMURAFENIB, AND VISMODEGIB IN PATIENTS WHO HAVE ADVANCED SOLID TUMORS WITH MUTATIONS OR GENE EXPRESSION ABNORMALITIES PREDICTIVE OF RESPONSE TO ONE OF THESE AGENTS
Study ID: Genentech ML28897/PRO 02 MY PATHWAY
Disease: Other
Stage: Phase IIA
  Learn More
A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers
Study ID: Incyte BMS INCB24360-204 Advanced Tumors
Disease: Other
Stage: Phase I/II
  Learn More
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Study ID: NCI Protocol #9671
Disease: Other
Stage: N/A
  Learn More
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module - 7 Ceritinib (LDK378) for patients whose tumors have aberrations in ALK or ROS1
Study ID: Novartis CLDK378AUS23 Signature
Disease:
Stage: Phase II
  Learn More
Cancer Registry Pilot Program
Study ID: PCORI COC Pilot Program
Disease: Other
Stage: Pilot/Feasibility
  Learn More
Children's
A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
Study ID: COG AHOD1331
Disease: Hodgkins Lymphoma, HOD (Hodgkin Disease)
Stage: Phase III
  Learn More
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
Study ID: COG ACNS02B3
Disease: CNS (Brain Tumors)
Stage: Unknown
  Learn More
Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
Study ID: COG ACNS0332
Disease: CNS (Brain Tumors)
Stage: Phase III
  Learn More
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years
Study ID: COG ACNS0831
Disease: CNS (Brain Tumors)
Stage: Phase III
  Learn More
A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
Study ID: COG ACNS1022
Disease: CNS (Brain Tumors)
Stage: Phase II
  Learn More
A Phase II Study For The Treatment Of Non- Metastatic Nodular Desmoplastic Medulloblastoma In Children Less Than 4 Years Of Age
Study ID: COG ACNS1221
Disease: CNS (Brain Tumors)
Stage: Phase II
  Learn More
Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLA-BSI) and Acquisition of Multi-Drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplnation (HCT)
Study ID: COG ACCL1034
Disease: AML (Acute Myelogenic Leukemia), Cancer Control, HEME (Hemetologic), CCL, SCT (Stem Cell Transplantation)
Stage: Phase III
  Learn More
Use of a Clinical Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Study ID: DCP-001 (Pediatric)
Disease: Cancer Control
Stage: N/A
  Learn More
A PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN (SGN35, IND# 117117) IN COMBINATION WITH GEMCITABINE FOR PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
Study ID: COG AHOD1221
Disease: Cancer Control, HOD (Hodgkin Disease)
Stage: Phase I/II
  Learn More
MPS VI Clinical Surveillance Program
Study ID: BioMarin MPS VI CSP
Disease: Other
Stage: Post Marketing
  Learn More
A Global, Multi-Center, Long-Term, Observational Survey of Patients with Hunter Syndrome (Mucopolysaccharidosis II)
Study ID: Shire HOS (hunter)
Disease: Other
Stage: Unknown
  Learn More
Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma
Study ID: COG ALTE11C1
Disease:
Stage: Unknown
  Learn More
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Study ID: SH NMES for Dysphagia in Neonates Khan
Disease: Esophagus, Head & Neck
Stage: Unknown
  Learn More
My Life Our Future: A Hemophilia Genotyping Initiative Data and Sample Research Repository
Study ID: Biogen My Life Our Future: A Hemophilia Genotyping Initiative
Disease: HEME (Hemetologic)
Stage: N/A
  Learn More
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Study ID: COG AALL05B1
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Unknown
  Learn More
Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Study ID: COG AALL08B1
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Unknown
  Learn More
Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Study ID: COG AALL0932
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum: A Groupwide Phase III Study
Study ID: COG AALL1131
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)
Study ID: COG AALL1231
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC# 765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Study ID: COG AALL1331
Disease: ALL (Acute Lymphocytic Leukemia)
Stage: Phase III
  Learn More
Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Study ID: COG AAML08B1
Disease: AML (Acute Myelogenic Leukemia)
Stage: Unknown
  Learn More
A Phase III Study for Patients with Newly Diagnosed Acute Promyelocytic Leukemia (APL) using Arsenic Trioxide and All-Trans Retinoic Acid
Study ID: COG AAML1331
Disease: APL, AML (Acute Myelogenic Leukemia)
Stage: Phase III
  Learn More
Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome A COG Groupwide Phase III Study
Study ID: COG AAML1531
Disease: AML (Acute Myelogenic Leukemia)
Stage: Phase III
  Learn More
A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Study ID: COG ACCL0933
Disease: AML (Acute Myelogenic Leukemia), CCL
Stage: Phase III
  Learn More
A Randomized Phase II Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, commercially labeled) in Combination with Chemotherapy for Newly Diagnosed Patients with Anaplastic Large Cell Lymphoma (ALCL) IND # 117117
Study ID: COG ANHL12P1
Disease: NHL (Non-Hodgkins Lymphoma)
Stage: Phase II
  Learn More
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Study ID: Seattle Childrens CFFC-OB-11
Disease:
Stage: Unknown
  Learn More
Renal Tumors Classification, Biology, and Banking Study
Study ID: COG AREN03B2
Disease: REN (Renal)
Stage: N/A
  Learn More
Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT)
Study ID: COG ACNS1123
Disease: CNS (Brain Tumors), GCT (Germ Cell Tumor)
Stage: Phase II
  Learn More
Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
Study ID: COG ALTE07C1
Disease: CNS (Brain Tumors), LTE (Late Effects), CCL
Stage: Unknown
  Learn More
Neuroblastoma Biology Studies
Study ID: COG ANBL00B1
Disease: NBL (Neuroblastoma)
Stage: Unknown
  Learn More
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Study ID: COG ANBL1232
Disease: NBL (Neuroblastoma)
Stage: Phase III
  Learn More
OPTIMIZing Treatment for Early Pseudomonas aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Randomized Trial
Study ID: Seattle Childrens OPTIMIZE Study
Disease:
Stage: Unknown
  Learn More
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Study ID: Vertex VX14-661-106 Phase III Program
Disease:
Stage: Phase III
  Learn More
A Children's Oncology Group Protocol for COllecting and Banking Ewing Sacroma Specimens
Study ID: COG AEWS07B1
Disease: EWS (Ewing Sarcoma)
Stage: Unknown
  Learn More
Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma
Study ID: COG AEWS1221
Disease: EWS (Ewing Sarcoma)
Stage: Phase II
  Learn More
A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
Study ID: COG AOST06B1
Disease: OST (Osteosarcoma)
Stage: Unknown
  Learn More
Phase 2 Study of Denosumab (IND# 127430, NSC# 744010), a RANK Ligand Antibody, for Recurrent or Refractory Osteosarcoma
Study ID: COG AOST1321
Disease: OST (Osteosarcoma)
Stage: Phase II
  Learn More
A Phase II Study of Human-Mouse Chimeric Anti-Disialoganglioside Monoclonal Antibody ch14.18 (Dinutuximab, NSC# 764038, IND# 4308) in Combination with Sargramostim (GM-CSF) in Patients with Recurrent Osteosarcoma
Study ID: COG AOST1421
Disease: OST (Osteosarcoma)
Stage: Phase II
  Learn More
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754, IND# 118613)
Study ID: COG ARST1321
Disease: Soft Tissue, RST (Soft Tissue Sarcoma)
Stage: Phase II/III
  Learn More
A COG Soft Tissue Sarcoma Biology and Banking Protocol
Study ID: COG D9902
Disease: RST (Soft Tissue Sarcoma)
Stage: Unknown
  Learn More
Key Adverse Events after Childhood Cancer
Study ID: COG ALTE03N1
Disease: LTE (Late Effects)
Stage: Unknown
  Learn More
Umbrella Long-Term Follow-Up Protocol
Study ID: COG ALTE05N1
Disease: LTE (Late Effects)
Stage: N/A
  Learn More
Diabetes/Thyroid
The Sanford Project TREX Study
Study ID: Caladrius CLBS03 P01 TREX Study
Disease:
Stage: Phase II
  Learn More
Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes
Study ID: Immune Tolerance Network ITN058AI EXTEND trial
Disease:
Stage: Phase II
  Learn More
Targeting ACE2/Angiotension-(1-7)/Mas axis to enhance vasoreparative function of endothelial progenitor cells in diabetes
Study ID: NDSU Vasoreparative Function Study
Disease:
Stage: N/A
  Learn More
Natural History Study of The Development of Type 1 Diabetes
Study ID: TrialNet TN-01
Disease: Pancreas
Stage: Unknown
  Learn More
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Study ID: TrialNet TN-07
Disease: Pancreas
Stage: Unknown
  Learn More
Heart
Abbott Absorb IV 10-392 ABSORB IV Randomized Controlled Trial, A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions.
Study ID: Abbott Absorb IV 10-392
Disease: Heart
Stage: IDE
  Learn More
A Multicenter, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab
Study ID: Amgen Evolocumab Extension Study 20140128 Glagov
Disease: Heart
Stage: Unknown
  Learn More
A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Chronic Heart Failure and Significant Coronary Artery Disease Following a Hospitalization for Exacerbation of Heart Failure
Study ID: Janssen Commander RIVAROXHFA3001
Disease: Heart
Stage: Phase III
  Learn More
A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to valsartan, on morbidity and mortality in heart failure patients (NYHA Class II-IV) with preserved ejection fraction
Study ID: Novartis LCZ696D2301 Ejection Fraction Heart FAilure Trial
Disease:
Stage: Phase III
  Learn More
JOSTENT Graft Master Coronary Stent Graft and Delivery System - A Humanitarian Use Device for use in the treatment of free perforations, defined as free contrast extravasations into the pericardium, in native vessels or saphenous vein bypass grafts greater than or equal to 2.75mm in diameter.
Study ID: Abbott JOSTENT GraftMaster
Disease: Heart
Stage: HDE
  Learn More
Sentus QP-Extended CRT Evaluation with Quadripolar Left Ventricular Leads
Study ID: Biotronik QP ExCELs
Disease: Heart
Stage: IDE
  Learn More
A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiac Surgery with Cardiopulmonary Bypass
Study ID: Grifols Antithrombin
Disease: Heart
Stage: Unknown
  Learn More
St Jude Cardiomems HF System Post Approval Study (PAS) Overview
Study ID: St Jude Cardiomems HF System Post Approval Study (PAS) Overview
Disease:
Stage: Post Marketing
  Learn More
A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Study ID: Tenax HCRI LEVO CTS
Disease: Heart
Stage: Phase III
  Learn More
Infectious Disease
An Open-label Safety Assessment of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection
Study ID: Rebiotix Punch SOS
Disease: Other
Stage: Unknown
  Learn More
Interventional Radiology
GREAT Global Registry for Endovascular Aortic Treatment Outcomes Evaluation
Study ID: W.L. Gore Endovascular Aortic Registry
Disease: Other
Stage: Registry
  Learn More
Nephrology
Enterra HDE Therapy System
Study ID: Medtronic Enterra H990014
Disease:
Stage: HDE
  Learn More
Neurology
A Prospective Registry Study in a Global Huntingtons Disease Cohort A CHDI Foundation Project
Study ID: CHDI Enroll HD
Disease: Other
Stage: Registry
  Learn More
LVIS
Study ID: Microvention HDE LVIS
Disease: Other
Stage: HDE
  Learn More
Investigating the neural mechanisms of working memory using transcranial magnetic stimulation and electroencephalographic recording in healthy subjects
Study ID: NDSU Jeff Johnson MRI Psychology Study
Disease:
Stage: N/A
  Learn More
Dystonia Coalition Projects
Study ID: NIH DCP 6301
Disease:
Stage: Registry
  Learn More
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Study ID: PCORI PAIN-CONTRoLS
Disease: Other
Stage: Unknown
  Learn More
HUD
Study ID: Stryker HDE Neuroform EZ Microdelivery Stent System
Disease: Other
Stage: HDE
  Learn More
HDE
Study ID: Stryker HDE Wingspan
Disease: Other
Stage: HDE
  Learn More
Treatment of progressive forms of Multiple Sclerosis with pulsed ACTH (Acthar gel)
Study ID: U of M ACTH Study
Disease:
Stage: Unknown
  Learn More
Orthopedics
CMC (Carpometacarpal) Joint Arthroplasty for Arthritis Comparing Outcomes and Cost of Arthrex® Mini TightRope® to the CMC Suture Suspension Technique
Study ID: SH CMC Joint Arthroplasty
Disease:
Stage: N/A
  Learn More
Endoscopic Decompression Compared to Open In Situ Release for the Treatment of Cubital Tunnel Syndrome (CuTS)
Study ID: SH Cubital Tunnel Study CuTS
Disease:
Stage: N/A
  Learn More
Vascular
Bard superficial femoral artery
Study ID: Bard CONTINUUM superficial femoral artery; BPV08001
Disease:
Stage: Post Marketing
  Learn More
A Phase II Clinical Study of the Safety and Performance of the Treovance Stent-Graft with Navitel Delivery System for Patients with Infrarenal Abdominal Aortic Aneurysms
Study ID: Bolton Medical IP-0008-12 Treovance Stent Graft
Disease:
Stage: Phase II
  Learn More
The US StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem Post Approval Study (DURABILITY PAS)
Study ID: EV3 Durablilty PAS CP-1001
Disease:
Stage: Post Marketing
  Learn More
SH VMS Visceral Manifold Study for the repair of thoracoabdominal aortic aneurysms
Study ID: SH VMS
Disease:
Stage: IDE
  Learn More
GORE® Carotid Stent Clinical Study for the treatment of carotid artery stenosis in patients at increased risk for adverse events from carotid endarterectomy
Study ID: WL GORE SCAFFOLD GCS 10-08
Disease:
Stage: IDE
  Learn More
Women's Health
Prospective, two-cohort, multi-center study comparing Restorelle Mesh to native tissue repair (No Mesh) in the transvaginal treatment of pelvic organ prolapse.
Study ID: Coloplast SU014 Restorelle 522
Disease:
Stage: Post Marketing
  Learn More
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR with Placebo in Female Subjects with Stress Urinary Incontinence
Study ID: Cook Myosite Inc Stress Urinary Incontinence 13-003
Disease:
Stage: Unknown
  Learn More
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Multi-Center Single Dose Study to Evaluate the Safety and Effectiveness of URG101 Compared with the Individual Components Lidocaine and Heparin in Subjects with Bladder Pain Syndrome and Interstitial Cystitis
Study ID: Urigen URG101-105 Bladder Instillation
Disease:
Stage: Phase IIA
  Learn More
Heart Sounds at Home: Prospective Maternal Surveillance of SSA Positive Pregnancies using a Hand-held Fetal Heart Rate Monitor
Study ID: University of Colorado COMIRB Heart Sounds
Disease: Other
Stage: Unknown
  Learn More
Other
The Sanford Health BioBank
Study ID: SH BioBank
Disease:
Stage: Unknown
  Learn More
Open-label study in subjects aged 12 years and older with the Homozygous or Heterozygous F508del-CFTR Mutation
Study ID: Vertex VX14-661-110 Extension Study
Disease: Lung
Stage: Unknown
  Learn More
A prospective observational study in cystic fibrosis patients with chronic respiratory Pseudomonas aeruginosa infection treated with TOBI Podhaler or other FDA approved inhaled antipseudomonal antibacterial drugs
Study ID: Novartis TOBI Podhaler CTBM100C2407
Disease: Lung
Stage: Unknown
  Learn More
Genetic Studies of Reproductive Disorders
Study ID: Medical College of Georgia GEORGIA
Disease:
Stage: Unknown
  Learn More